Sinobiopharma has entered into an two-year export deal with Kingchem, a US-based international marketing organization that specializes in custom manufacturing and sourcing of pharmaceuticals. Kingchem will act as Sinobiopharma’s agent to find a US partner to co-develop Sinobiopharma's China patented version of Cisatracurim besylate, a non-depolarizing pre-surgical skeletal muscle relaxant, for use in the US. More details...

Stock Symbol: (OTCBB: SNBP)